Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY46.69 CNY
Change Today +2.19 / 4.92%
Volume 74.3M
600518 On Other Exchanges
Symbol
Exchange
Shanghai
As of 11:30 PM 06/1/15 All times are local (Market data is delayed by at least 15 minutes).

kangmei pharmaceutical co-a (600518) Snapshot

Open
CNY46.50
Previous Close
CNY44.50
Day High
CNY47.75
Day Low
CNY45.45
52 Week High
06/2/15 - CNY47.75
52 Week Low
07/18/14 - CNY13.80
Market Cap
102.7B
Average Volume 10 Days
102.2M
EPS TTM
CNY1.14
Shares Outstanding
2.2B
EX-Date
--
P/E TM
40.9x
Dividend
CNY0.32
Dividend Yield
0.56%
Current Stock Chart for KANGMEI PHARMACEUTICAL CO-A (600518)

Related News

No related news articles were found.

kangmei pharmaceutical co-a (600518) Related Businessweek News

No Related Businessweek News Found

kangmei pharmaceutical co-a (600518) Details

Kangmei Pharmaceutical Co., Ltd. manufactures and sells pharmaceuticals and medical devices in China. The company's principal products comprise Chinese medicines, including American ginseng, notoginseng powder, salvia powder, radix codonopsis pilosulae, maltiflower knotweed, angelica, lonicera flower, and others. It also offers chemical drugs, such as clarithromycin dispersible tablets, doxazosin mesylate tablets, propiverine hydrochloride tablets, paracetamol, pseudoephedrine hydrochloride tablets, and others. In addition, the company wholesales and retails in other medical materials comprising bird's nest, ganoderma, sea horse, isinglass, forest frog, and others. Kangmei Pharmaceutical Co., Ltd. was founded in 1997 and is based in Jieyang, China.

Founded in 1997

kangmei pharmaceutical co-a (600518) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

kangmei pharmaceutical co-a (600518) Key Developments

Kangmei Pharmaceutical Co., Ltd. Signs Strategic Cooperation Agreement with Guangxi Wuzhou Zhongheng Group

Kangmei Pharmaceutical Co., Ltd. announced the singing agreement on strategic cooperation with Guangxi Wuzhou Zhongheng Group Co., Ltd.

Kangmei Pharmaceutical Co., Ltd. to Report Q1, 2015 Results on Apr 28, 2015

Kangmei Pharmaceutical Co., Ltd. announced that they will report Q1, 2015 results on Apr 28, 2015

Kangmei Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter of 2015

Kangmei Pharmaceutical Co., Ltd. reported earnings results for the first quarter of 2015. For the period, the company reported basic earnings per share of CNY 0.372 and weighted average return on net assets of 4.77%.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
600518:CH CNY46.69 CNY +2.19

600518 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 600518.
View Industry Companies
 

Industry Analysis

600518

Industry Average

Valuation 600518 Industry Range
Price/Earnings 38.9x
Price/Sales 5.8x
Price/Book 6.7x
Price/Cash Flow 38.9x
TEV/Sales 4.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KANGMEI PHARMACEUTICAL CO-A, please visit www.kangmei.com.cn. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.